News

The U.S. Food and Drug Administration has accepted Novo Nordisk's marketing application for an oral version of its ...
The Bagsvaerd, Denmark, company said that if the application is approved, Wegovy would become the first oral formulation of a ...
The $560 million company will stop selling products at Woolworths and Priceline and concentrate on selling weight-loss drugs ...
A decision is expected in the fourth quarter of 2025.
Starting July 1, Wegovy will become the preferred GLP-1 for obesity treatment on CVS Caremark’s largest commercial template ...
Aetna is once again retreating from the Affordable Care Act market, while its parent company notched a deal with Danish ...
Novo Nordisk A/S said it would sell its popular weight-loss drug Wegovy for a steeply reduced price on several telehealth ...
Novo Nordisk is expanding access to its GLP-1 drug Wegovy via telehealth, partnering with Hims and Hers, Ro, and LifeMD.